<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35199">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01971320</url>
  </required_header>
  <id_info>
    <org_study_id>2013/002/HP</org_study_id>
    <nct_id>NCT01971320</nct_id>
  </id_info>
  <brief_title>Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia</brief_title>
  <acronym>TENSDEG</acronym>
  <official_title>Evaluation of Transcutaneous Electrical Stimulation in Post Stroke Dysphagia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Oropharyngeal dysphagia induces aspirations which could be responsible of aspiration
      pneumonia and denutrition. It could be present in the majority of central neurological
      disease (degenerative or vascular disease), which explains that it is the first case of
      mortality in stroke. Two pilot studies realised by our research group aimed to demonstrate
      that sensitive transcutaneous electrical stimulation could improve swallowing coordination
      and reduce aspirations. This technique could be used at home.

      The aim of this study is to demonstrate that sensitive electrical stimulation could improve
      oropharyngeal dysphagia in hemispheric stroke patients. 118 patients should be included in
      seven centers. Sensitive electrical stimulation will be applied either as active
      stimulation, either as a placebo. Active electrical stimulation will be realised at 80 hz
      during 30 minutes, under motor threshold and above sensitive threshold. It will be
      administrated via surface electrodes over the hyoid bone. Patients will be separated by
      randomisation.

      Patients will be evaluated before and after 6 weeks of use. Methods will evaluation
      questionnaire, clinical examination and videofluoroscopy. The time of use will also be
      collected.

      We wish to demonstrate that transcutaneous electrical stimulation is able to improve
      oropharyngeal dysphagia in stroke.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Evaluation of oropharyngeal dysphagia symptoms</measure>
    <time_frame>Week 6</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation of oropharyngeal dysphagia symptoms by questionnaire (dysphagia handicap index)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of oropharyngeal dysphagia symptoms</measure>
    <time_frame>Week 6</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluation of oropharyngeal dysphagia symptoms by videofluoroscopy and Swal-QoL questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">118</enrollment>
  <condition>Oropharyngeal Dysphagia</condition>
  <condition>Deglutition Disorders</condition>
  <arm_group>
    <arm_group_label>active stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sensitive electrical stimulation applied during meals with Urostim I for 6 weeks
Urostim I stimulation will be done during meals for 6 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fake stimulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Urostim I stimulation will be done during meals for 6 weeks
Fake sensitive electrical stimulation applied during meals with modified Urostim I who not deliver stimulation for 6 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Urostim I stimulation</intervention_name>
    <description>Urostim I stimulation will be done during meals for 6 weeks</description>
    <arm_group_label>active stimulation</arm_group_label>
    <arm_group_label>fake stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 85 years

          -  No contraindication to electrical stimulation

          -  Oropharyngeal dysphagia from 8 weeks diagnosed by videofluorosocpy with penetration
             aspiration scale &gt; 3 or a residue ≥ 50%

          -  Due to an hemispheric stroke

          -  Patients able to understand the videofluroscopy and questionnaires

          -  For women in age of procreation, to have a contraception, a pregnacy test will be
             done if not

          -  Able to swallow (a nasogastric tube is not a contraindication to participate)

        Exclusion Criteria:

          -  Pregnancy or breast feeding

          -  Psychiatric illnes

          -  Swallowing disorders before the stroke

          -  Contraindication to electrical stimulation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric VERIN, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>UH Rouen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric VERIN, Professor</last_name>
    <phone>+3323288</phone>
    <phone_ext>8039</phone_ext>
    <email>eric.verin@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julien BLOT, M</last_name>
    <phone>+3323288²</phone>
    <phone_ext>8265</phone_ext>
    <email>julien.blot@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre les Herbiers</name>
      <address>
        <city>Bois-Guillaume</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric VERIN, Professor</last_name>
      <phone>+3323559</phone>
      <phone_ext>0214</phone_ext>
      <email>eric.verin@ugecam-normandie.fr</email>
    </contact>
    <investigator>
      <last_name>Eric VERIN, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UH Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick DEHAIL, Professor</last_name>
      <phone>+3355655.</phone>
      <phone_ext>6557</phone_ext>
      <email>patrick.dehail@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick DEHAIL, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UH Limoges</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean Y SALLE, Professor</last_name>
      <phone>+335 55 05</phone>
      <phone_ext>6518</phone_ext>
      <email>Jean-Yves.Salle@chu-limoges.fr</email>
    </contact>
    <investigator>
      <last_name>Jean Y SALLE, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AP-HP Fernand WIDAL</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alain YELNICK, Professor</last_name>
      <phone>+3314005</phone>
      <phone_ext>42 05</phone_ext>
      <email>alain.yelnik@lrb.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Alain YELNICK, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UH Rouen</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric VERIN, Professor</last_name>
      <phone>+3323288</phone>
      <phone_ext>8039</phone_ext>
      <email>eric.verin@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Eric VERIN, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UH Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xavier DE BOISSEZON, Professor</last_name>
      <phone>+3356132</phone>
      <phone_ext>2801</phone_ext>
      <email>deboissezon.xavier@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Xavier DE BOISSEZON, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie WOISARD, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 23, 2013</lastchanged_date>
  <firstreceived_date>October 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Deglutition Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
